Michel Detheux
Login to view DISC.Michel Detheux is a biotechnology executive with over 30 years of experience, serving as the co-founder, President, and CEO of iTeos Therapeutics. He has guided the company from its preclinical stage to a publicly traded entity, securing over $1. 2 billion through a NASDAQ IPO and strategic partnerships. He holds a Ph. D. in Biochemistry and completed post-doctoral studies at the University of Glasgow.
There is no publicly available information about his personal life or hobbies, as his focus appears to be primarily on his professional endeavors in the biotechnology industry.
He orchestrated one of the largest upfront strategic deals for an early-stage asset with GlaxoSmithKline, valued at over $2 billion, to co-develop an anti-TIGIT antibody.
Read the full overview →How Michel shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Michel cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.